Having trouble accessing articles? Reset your cache.

Autologous bone marrow mononuclear cells: Phase II data

Researchers at the hospital and colleagues reported data from the double-blind, U.S. Phase II Late TIME trial in 87 patients with

Read the full 219 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE